Noninvasive Liver Fibrosis Markers in the Evaluation of Fibrosis Regression After Direct-Acting Antiviral Therapy
Author:
Affiliation:
1. Infectious Diseases Unit, Hospital de Galdácano-Usansolo , Galdácano , Spain
2. Infectious Diseases-HIV Unit, Hospital Universitario Central de Asturias, Microbiology and Infectious Diseases Group, FINBA-ISPA , Oviedo , Spain
Funder
Fondo de Investigaciones Sanitarias
ViiV Healthcare
Publisher
Oxford University Press (OUP)
Link
https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae095/57021042/jiae095.pdf
Reference9 articles.
1. Longitudinal assessment of the enhanced liver fibrosis score in the era of contemporary HIV and hepatitis C virus treatment;Gardner;J Infect Dis,2023
2. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy;Pérez-Is;Sci Rep,2022
3. Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors;Latronico;Int J Mol Sci,2016
4. Direct-acting antiviral therapy for chronic HCV infection results in liver stiffness regression over 12 months posttreatment;Chan;Dig Dis Sci,2018
5. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents;Hsu;BMC Gastroenterol,2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3